PDCD1LG2 and sarcoma: The existing study examined the expression levels of PD-L1, PD-L2, and PD-1 in multiple sarcomas including osteosarcoma and the PD-1 axis effectors are differentially expressed in various sarcomas varying from 0 to 40%16.